Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Common Stock
Additional Paid in Capital (Deficit)
Retained Deficit
Retained Deficit
Cumulative Effect Period of Adoption Adjustment
Beginning Balance at Sep. 29, 2018 $ (888,949)   $ 157 $ (281,978) $ (607,128)  
Beginning Balance, Shares at Sep. 29, 2018     156,500      
Equity-based compensation 2,130     2,130    
Payment of dividend (1,240)       (1,240)  
Net income 702       702  
Ending Balance at Sep. 28, 2019 (887,357) $ 12 $ 157 (279,848) (607,666) $ 12
Ending Balance, Shares at Sep. 28, 2019     156,500      
Equity-based compensation 1,785     1,785    
Net income 58,561       58,561  
Ending Balance at Oct. 03, 2020 (826,999)   $ 157 (278,063) (549,093)  
Ending Balance, Shares at Oct. 03, 2020     156,500      
Vesting of restricted stock units 3   $ 3      
Vesting of restricted stock units, Shares     3,321      
Issuance of common stock upon initial public offering, net of offering costs 458,587   $ 30 458,557    
Issuance of common stock upon initial public offering, net of offering costs, Shares     30,000      
Equity-based compensation 24,217     24,217    
Net income 126,634       126,634  
Ending Balance at Oct. 02, 2021 $ (217,558)   $ 190 $ 204,711 $ (422,459)  
Ending Balance, Shares at Oct. 02, 2021     189,821